Literature DB >> 24568460

Insights into the diverse roles of miR-205 in human cancers.

Ayla Valinezhad Orang1, Reza Safaralizadeh, Mohammad Ali Hosseinpour Feizi.   

Abstract

The recent discovery of tiny microRNAs (miRNAs) has brought about awareness of a new class of regulators of diverse pathways in many physiological and pathological processes, such as tumorigenesis. They modulate gene expression by targeting plethora of mRNAs, mostly reducing the protein yield of a targeted mRNA. With accumulation of information on characteristics of miR-205, complex and in some cases converse roles of miR-205 in tumor initiation, progression and metastasis are emerging. miR-205 acts either as an oncogene via facilitating tumor initiation and proliferation, or in some cases as a tumor suppressor through inhibiting proliferation and invasion. The aim of this review is to discuss miR-205 roles in different types of cancers. Given the critical effects of deregulated miR-205 on processes involved in tumorigenesis, they hold potential as novel therapeutic targets and biomarkers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24568460     DOI: 10.7314/apjcp.2014.15.2.577

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  19 in total

1.  Comparison of exosomal microRNAs secreted by 786-O clear cell renal carcinoma cells and HK-2 proximal tubule-derived cells in culture identifies microRNA-205 as a potential biomarker of clear cell renal carcinoma.

Authors:  Victor C Crentsil; Hui Liu; Donald F Sellitti
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

2.  MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.

Authors:  Renata Hezova; Alena Kovarikova; Josef Srovnal; Milada Zemanova; Tomas Harustiak; Jiri Ehrmann; Marian Hajduch; Milana Sachlova; Marek Svoboda; Ondrej Slaby
Journal:  Tumour Biol       Date:  2015-12-28

3.  The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.

Authors:  Max Michael Traeger; Jan Rehkaemper; Hansjoerg Ullerich; Konrad Steinestel; Eva Wardelmann; Norbert Senninger; Sameer Abdallah Dhayat
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-22       Impact factor: 4.553

4.  Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy.

Authors:  Michael E Wilhide; James D Feller; Birong Li; Ahmad Z Mohamed; Brian Becknell; Ashley R Jackson; Kirk M McHugh; Susan E Ingraham
Journal:  Pediatr Res       Date:  2016-06-07       Impact factor: 3.756

Review 5.  Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation.

Authors:  Ayla Valinezhad Orang; Reza Safaralizadeh; Mina Kazemzadeh-Bavili
Journal:  Int J Genomics       Date:  2014-08-10       Impact factor: 2.326

6.  Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells.

Authors:  Mikiro Takaishi; Masahito Tarutani; Junji Takeda; Shigetoshi Sano
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

7.  Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.

Authors:  Robert Gelfand; Dolores Vernet; Kevin Bruhn; Jaydutt Vadgama; Nestor F Gonzalez-Cadavid
Journal:  Int J Oncol       Date:  2016-03-29       Impact factor: 5.650

8.  MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy.

Authors:  Katerina Popovska-Jankovic; Predrag Noveski; Ljubinka Jankovic-Velickovic; Slavica Stojnev; Rade Cukuranovic; Vladisav Stefanovic; Draga Toncheva; Rada Staneva; Momir Polenakovic; Dijana Plaseska-Karanfilska
Journal:  Biomed Res Int       Date:  2016-04-27       Impact factor: 3.411

9.  Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells.

Authors:  D-W Yeh; Y-S Chen; C-Y Lai; Y-L Liu; C-H Lu; J-F Lo; L Chen; L-C Hsu; Y Luo; R Xiang; T-H Chuang
Journal:  Cell Death Differ       Date:  2015-11-20       Impact factor: 15.828

10.  Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.

Authors:  Trang Nguyen-Vu; Jun Wang; Fahmi Mesmar; Srijita Mukhopadhyay; Ashish Saxena; Catherine W McCollum; Jan-Åke Gustafsson; Maria Bondesson; Cecilia Williams
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.